Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 12Esophageal Squamous Cell Carcinoma 11Pancreatic Neoplasms 8Stomach Neoplasms 4Colorectal Neoplasms 3Pancreatic cancer, adult 2Squamous Cell Carcinoma of Anal Canal 1Resectable Pancreatic Cancer 1Pancreatic Cancer Resectable 1Neoplasm Metastasis 1Locally Advanced Rectal Cancer 1Esophageal 1Advanced Pancreatic Cancer 1Advanced Esophageal 1Advanced Colorectal Cancer 1Adenocarcinoma 1

Interventions

nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Esophageal × nimotuzumab × Gastrointestinal × Clear all
NCT00950417 2015-08-19

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Biotech Pharmaceutical Co., Ltd.

Phase 1 Completed
11 enrolled
Gastrointestinal

Advanced Esophageal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡